<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05060874</url>
  </required_header>
  <id_info>
    <org_study_id>2021-A00927-34</org_study_id>
    <nct_id>NCT05060874</nct_id>
  </id_info>
  <brief_title>Gripwise® Versus JAMAR®</brief_title>
  <acronym>HANDGAGES</acronym>
  <official_title>Comparison of Gripstrength Assessment Between the Gripwise® and JAMAR® Dynamometers in Elderly Inpatients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Caen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Caen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      It is recommended to screen ageing patients for sarcopenia, due to the increased risk of&#xD;
      morbimortality if detected positive. According to the consensus of the European Working Group&#xD;
      on Sarcopenia in Older People, the diagnosis of sarcopenia is based, among other things, on&#xD;
      grip strength measurement.&#xD;
&#xD;
      Our study will compare the performance of the new GRIPWISE digital device with the mechanical&#xD;
      dynamometer JAMAR, the gold standard currently used to assess the grip strength. We propose&#xD;
      to evaluate it in an elderly hospitalized population where the prevalence of sarcopenia is&#xD;
      likely to be high due to the high prevalence of various chronic illness, notably oncological&#xD;
      and cardiological ones.&#xD;
&#xD;
      This cross-sectional study will include 348 patients.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2021</start_date>
  <completion_date type="Anticipated">November 30, 2021</completion_date>
  <primary_completion_date type="Actual">September 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Comparison between Jamar® and Gripwise® values for grip strength measurement</measure>
    <time_frame>day1</time_frame>
    <description>Intra-class correlation between the best values obtained with each device</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>comparison according to the patient's position</measure>
    <time_frame>day1</time_frame>
    <description>correlations of dynamometer measurements between patients assessed in the sitting or lying position</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>number of attempt to reach the maximum value</measure>
    <time_frame>day1</time_frame>
    <description>Comparison of the three measurements obtained for each patient with each device</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>factors influencing detected weakness</measure>
    <time_frame>day1</time_frame>
    <description>significant difference in the rate of women detected as weak with a handgrip &lt;16kg and men &lt;27kg, between the different reasons for hospitalisation, the number of days of hospitalisation, and between the different chronic cancerous and non-cancerous pathologies (Updated Charlson Comorbidity Index), the age groups 65-79 years and ≥80 years</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>satisfaction using the devices</measure>
    <time_frame>day1</time_frame>
    <description>rate of patients finding one of both device easier to use</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">348</enrollment>
  <condition>Age-Related Sarcopenia</condition>
  <arm_group>
    <arm_group_label>single group</arm_group_label>
    <description>gripwise or jamar will be randomly assessed first</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        aged inpatients hospitalized in CAEN University Hospital&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  men and women aged 65 or over&#xD;
&#xD;
          -  affiliated to a health insurance&#xD;
&#xD;
          -  Francophone.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  - refusal to participate&#xD;
&#xD;
          -  unable to communicate&#xD;
&#xD;
          -  unable to use both hands (dominant and non-dominant)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bérengère Beauplet, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Caen UH</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>François Fournel</last_name>
    <phone>+33231065488</phone>
    <email>fournel-f@chu-caen.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Caen University Hospital</name>
      <address>
        <city>Caen</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bérengère Beauplet, PhD</last_name>
      <email>beauplet-b@chu-caen.fr</email>
    </contact>
    <investigator>
      <last_name>Cédric Villain, MDPHD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Soazig Lebaube, RN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sandra Ramel, RN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Corinne Kremer, RN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 22, 2021</study_first_submitted>
  <study_first_submitted_qc>September 22, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 29, 2021</study_first_posted>
  <last_update_submitted>September 22, 2021</last_update_submitted>
  <last_update_submitted_qc>September 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Caen</investigator_affiliation>
    <investigator_full_name>Bérengère</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>aged</keyword>
  <keyword>inpatients</keyword>
  <keyword>hand strength</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sarcopenia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

